LakeShore Biopharma Co Ltd (LSB)
0.60
+0.02
(+2.56%)
USD |
NASDAQ |
Jun 21, 16:00
0.6059
+0.01
(+0.98%)
After-Hours: 20:00
LakeShore Biopharma Total Liabilities (Quarterly): 144.48M for Sept. 30, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 144.48M |
| June 30, 2023 | 141.87M |
| Date | Value |
|---|---|
| September 30, 2022 | 350.70M |
| March 31, 2022 | 336.71M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
141.87M
Minimum
Jun 2023
350.70M
Maximum
Sep 2022
243.44M
Average
240.60M
Median
Total Liabilities (Quarterly) Benchmarks
| Sinovac Biotech Ltd | 1.635B |
| CASI Pharmaceuticals Inc | 42.54M |
| Zai Lab Ltd | 226.27M |
| China SXT Pharmaceuticals Inc | 9.512M |
| Adagene Inc | 45.17M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 220.84M |
| Shareholders Equity (Quarterly) | 76.35M |
| Debt to Equity Ratio | 0.9778 |
| Current Ratio | 1.409 |
| Net Debt Paydown Yield | -10.09% |